• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New Study Connects Skin Barrier Dysfunction to Pediatric Eosinophilic Esophagitis

Bioengineer by Bioengineer
September 6, 2025
in Health
Reading Time: 3 mins read
0
New Study Connects Skin Barrier Dysfunction to Pediatric Eosinophilic Esophagitis
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A pioneering study spearheaded by researchers at National Jewish Health has unveiled compelling evidence pointing to the skin as an innovative, non-invasive biomarker for eosinophilic esophagitis (EoE), a chronic allergic condition affecting the esophagus in children. Traditionally diagnosed through invasive endoscopic procedures, EoE’s elusive nature has challenged clinicians, particularly in pediatric patients who lack overt skin symptoms. This groundbreaking research opens a promising avenue by employing skin tape stripping, an accessible technique that could radically transform diagnosis and monitoring of this debilitating disease.

The investigative team, including Elena Goleva, PhD, and Donald Y. Leung, MD, PhD, working in concert with Seema Aceves, MD, PhD of the University of California San Diego, centered their exploration on ceramides—specialized lipid molecules integral to skin barrier integrity and function. Ceramides are pivotal in maintaining the epidermal barrier, regulating hydration, and protecting against environmental insults. Disruptions in ceramide synthesis have been extensively linked to skin disorders such as atopic dermatitis, yet their involvement in esophageal allergic conditions was hitherto underappreciated.

Published in the prestigious Journal of Allergy and Clinical Immunology, the study meticulously demonstrated that children suffering from EoE, even those without clinical signs of eczema or other skin diseases, exhibit pronounced deficiencies in long-chain and ultralong-chain ceramides in their skin. These lipid abnormalities suggest a systemic epithelial barrier dysfunction that transcends the traditional compartmentalized understanding of allergic diseases localized to either skin or esophagus.

.adsslot_igX2wMe6lf{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_igX2wMe6lf{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_igX2wMe6lf{ width:320px !important; height:50px !important; } }

ADVERTISEMENT

Eosinophilic esophagitis is an immune-mediated inflammatory disorder characterized by an eosinophil-predominant infiltration of the esophageal mucosa, leading to tissue remodeling and symptomatic esophageal dysfunction. The disease is often comorbid with atopic conditions such as asthma, food allergies, and particularly atopic dermatitis. Despite this connection, no reliable surrogate markers have existed, complicating early diagnosis and disease monitoring without resorting to invasive endoscopy.

Dr. Goleva emphasized the significance of these findings, asserting that “our research provides the first evidence that skin barrier lipid abnormalities exist in EoE independently of visible skin disease.” This suggests a unified epithelial barrier hypothesis wherein disrupted lipid metabolism may govern susceptibility and pathogenesis across allergic tissues. Such a paradigm challenges previous concepts and invites a broader investigation of cutaneous and mucosal immune interactions.

By highlighting the shared dysregulation of ceramide synthesis in the skin of EoE patients, the research advances the hypothesis that epithelial barrier defects may constitute a foundational element in diverse allergic diseases. The presence of similar lipid abnormalities in both atopic dermatitis and EoE suggests that therapeutic interventions targeting lipid metabolism might hold promise for multi-organ allergic conditions, potentially revolutionizing disease management strategies.

This novel skin tape stripping technique, by circumventing the necessity for invasive endoscopic procedures, holds the potential to streamline patient care. Dr. Leung noted that “if validated in larger cohorts, this simple and non-invasive skin test could transform clinical practice by allowing early detection and monitoring of eosinophilic esophagitis through skin lipid profiling.” Such innovation promises to reduce patient burden and healthcare costs substantially.

Furthermore, the parallels drawn between skin and esophageal barrier impairments open intriguing questions regarding shared genetic and environmental factors influencing ceramide metabolism. Future studies could explore how dietary components, microbiome alterations, and epigenetic modifications interact to modulate epithelial lipid homeostasis and susceptibility to allergic inflammation.

As this research continues to evolve, the integration of lipidomic profiling into routine clinical workflows could foster personalized medicine approaches for allergic diseases. By defining precise molecular profiles of barrier dysfunction, clinicians might tailor interventions such as ceramide supplementation or novel lipid-targeted therapies to individual patient needs.

Overall, the findings by the National Jewish Health team illuminate a transformative path forward in understanding and managing eosinophilic esophagitis. By bridging dermatology and gastroenterology through lipid metabolism, this study reshapes the landscape of allergic disease diagnosis and offers hope for less invasive, more effective diagnostic tools to ultimately improve pediatric patient care worldwide.

Subject of Research: Eosinophilic esophagitis and skin barrier lipid abnormalities in pediatric patients

Article Title: Cutaneous ceramide synthesis is dysregulated in pediatric eosinophilic esophagitis

News Publication Date: 5-Jun-2025

Web References:

https://www.nationaljewish.org/doctors-departments/elena-goleva
https://www.nationaljewish.org/doctors-departments/donald-y-m-leung
https://www.jacionline.org/article/S0091-6749(25)00220-9/fulltext

Keywords: Atopic dermatitis, eosinophilic esophagitis, ceramides, skin barrier, lipidomics, epithelial barrier dysfunction, pediatric allergy, non-invasive diagnostics

Tags: allergic conditions in pediatric patientsceramides and skin healthchronic allergic conditions in childrenendoscopic procedures for EoE diagnosisinnovative biomarkers for EoEJournal of Allergy and Clinical Immunology studymonitoring eosinophilic esophagitisnon-invasive diagnosis techniquespediatric eosinophilic esophagitisrelationship between skin disorders and EoEskin barrier dysfunction in childrenskin tape stripping method

Share14Tweet9Share2ShareShareShare2

Related Posts

“Bioavailability of Umbelliferone: Metabolism & Extraction Insights”

September 11, 2025

Inner Cell Mass and Blastulation Impact Pregnancy Success

September 11, 2025

New Research Reveals Indigenous Amazon Forests Help Curb Spread of 27 Diseases Across Eight Countries

September 11, 2025

Indigenous Amazon Territories Promote Human Health, Study Finds

September 11, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

“Bioavailability of Umbelliferone: Metabolism & Extraction Insights”

Scientist, Advocate, and Entrepreneur Lucy Shapiro Honored with Lasker-Koshland Special Achievement Award

Breakthrough Nano-Switch Enables Precise Control of Chargeless Quantum Information Flow

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.